These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33724342)

  • 1. Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition.
    Bhargava P; Kim S; Reyes AA; Grenningloh R; Boschert U; Absinta M; Pardo C; Van Zijl P; Zhang J; Calabresi PA
    Brain; 2021 Jun; 144(5):1396-1408. PubMed ID: 33724342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions.
    Gupta K; Kesharwani A; Rua S; Singh SS; Siu C; Jank L; Smith MD; Calabresi PA; Bhargava P
    J Neuroinflammation; 2023 Oct; 20(1):229. PubMed ID: 37805549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Bruton's tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease.
    Torke S; Pretzsch R; Häusler D; Haselmayer P; Grenningloh R; Boschert U; Brück W; Weber MS
    Acta Neuropathol; 2020 Oct; 140(4):535-548. PubMed ID: 32761407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.
    Pol S; Schweser F; Bertolino N; Preda M; Sveinsson M; Sudyn M; Babek N; Zivadinov R
    Exp Neurol; 2019 Apr; 314():82-90. PubMed ID: 30684521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair.
    Geladaris A; Torke S; Saberi D; Alankus YB; Streit F; Zechel S; Stadelmann-Nessler C; Fischer A; Boschert U; Häusler D; Weber MS
    Acta Neuropathol; 2024 Apr; 147(1):75. PubMed ID: 38656399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
    Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
    J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal resolution of spinal meningeal and parenchymal inflammation during experimental autoimmune encephalomyelitis.
    Shrestha B; Jiang X; Ge S; Paul D; Chianchiano P; Pachter JS
    Neurobiol Dis; 2017 Dec; 108():159-172. PubMed ID: 28844788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.
    Haselmayer P; Camps M; Liu-Bujalski L; Nguyen N; Morandi F; Head J; O'Mahony A; Zimmerli SC; Bruns L; Bender AT; Schroeder P; Grenningloh R
    J Immunol; 2019 May; 202(10):2888-2906. PubMed ID: 30988116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Meningeal T and Plasma Cell Infiltration is Associated with Early Subpial Cortical Demyelination in Common Marmosets with Experimental Autoimmune Encephalomyelitis.
    Kramann N; Neid K; Menken L; Schlumbohm C; Stadelmann C; Fuchs E; Brück W; Wegner C
    Brain Pathol; 2015 May; 25(3):276-86. PubMed ID: 25041171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bruton's tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination.
    Evonuk KS; Wang S; Mattie J; Cracchiolo CJ; Mager R; Ferenčić Ž; Sprague E; Carrier B; Schofield K; Martinez E; Stewart Z; Petrosino T; Johnson GA; Yusuf I; Plaisted W; Naiman Z; Delp T; Carter L; Marušić S
    Acta Neuropathol Commun; 2023 Jul; 11(1):115. PubMed ID: 37438842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation and immunomodulatory function of meningeal B cell aggregates in progressive CNS autoimmunity.
    Mitsdoerffer M; Di Liberto G; Dötsch S; Sie C; Wagner I; Pfaller M; Kreutzfeldt M; Fräßle S; Aly L; Knier B; Busch DH; Merkler D; Korn T
    Brain; 2021 Jul; 144(6):1697-1710. PubMed ID: 33693558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
    Montalban X; Arnold DL; Weber MS; Staikov I; Piasecka-Stryczynska K; Willmer J; Martin EC; Dangond F; Syed S; Wolinsky JS;
    N Engl J Med; 2019 Jun; 380(25):2406-2417. PubMed ID: 31075187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.
    Howell OW; Reeves CA; Nicholas R; Carassiti D; Radotra B; Gentleman SM; Serafini B; Aloisi F; Roncaroli F; Magliozzi R; Reynolds R
    Brain; 2011 Sep; 134(Pt 9):2755-71. PubMed ID: 21840891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of B cells to cortical damage in multiple sclerosis.
    Bhargava P; Hartung HP; Calabresi PA
    Brain; 2022 Oct; 145(10):3363-3373. PubMed ID: 35775595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.
    Magliozzi R; Columba-Cabezas S; Serafini B; Aloisi F
    J Neuroimmunol; 2004 Mar; 148(1-2):11-23. PubMed ID: 14975582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
    Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice.
    Wang X; Cusick MF; Wang Y; Sun P; Libbey JE; Trinkaus K; Fujinami RS; Song SK
    NMR Biomed; 2014 Jul; 27(7):843-52. PubMed ID: 24816651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.
    Church ME; Ceja G; McGeehan M; Miller MC; Farias P; Sánchez MD; Swain GP; Assenmacher CA; Stopa EG; Vite CH; Bar-Or A; Alvarez JI
    J Immunol; 2021 Jul; 207(1):44-54. PubMed ID: 34162727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration-QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy Volunteers.
    Becker A; Martin EC; Mitchell DY; Grenningloh R; Bender AT; Laurent J; Mackenzie H; Johne A
    Clin Transl Sci; 2020 Mar; 13(2):325-336. PubMed ID: 31654487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis.
    Torke S; Weber MS
    Expert Opin Investig Drugs; 2020 Oct; 29(10):1143-1150. PubMed ID: 32772592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.